BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 17133181)

  • 1. Influence of drotrecogin alpha (activated) infusion on the variation of Bax/Bcl-2 and Bax/Bcl-xl ratios in circulating mononuclear cells: a cohort study in septic shock patients.
    Bilbault P; Lavaux T; Launoy A; Gaub MP; Meyer N; Oudet P; Pottecher T; Jaeger A; Schneider F
    Crit Care Med; 2007 Jan; 35(1):69-75. PubMed ID: 17133181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-10 gene down-expression in circulating mononuclear cells during infusion of drotrecogin-α activated: a pilot study.
    Lavaux T; Bilbault P; Launoy A; Gaub MP; Oudet P; Schneider F
    Crit Care; 2010; 14(5):R163. PubMed ID: 20825636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of drotrecogin alfa activated on microcirculatory alterations in patients with severe sepsis.
    De Backer D; Verdant C; Chierego M; Koch M; Gullo A; Vincent JL
    Crit Care Med; 2006 Jul; 34(7):1918-24. PubMed ID: 16715034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activated protein C and septic shock: a propensity-matched cohort study*.
    Rimmer E; Kumar A; Doucette S; Marshall J; Dial S; Gurka D; Dellinger RP; Sharma S; Penner C; Kramer A; Wood K; Ronald J; Kumar A; Turgeon AF; Houston DS; Zarychanski R;
    Crit Care Med; 2012 Nov; 40(11):2974-81. PubMed ID: 22932397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant human activated protein C for adults with septic shock: a randomized controlled trial.
    Annane D; Timsit JF; Megarbane B; Martin C; Misset B; Mourvillier B; Siami S; Chagnon JL; Constantin JM; Petitpas F; Souweine B; Amathieu R; Forceville X; Charpentier C; Tesnière A; Chastre J; Bohe J; Colin G; Cariou A; Renault A; Brun-Buisson C; Bellissant E;
    Am J Respir Crit Care Med; 2013 May; 187(10):1091-7. PubMed ID: 23525934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extended drotrecogin alfa (activated) treatment in patients with prolonged septic shock.
    Dhainaut JF; Antonelli M; Wright P; Desachy A; Reignier J; Lavoue S; Charpentier J; Belger M; Cobas-Meyer M; Maier C; Mignini MA; Janes J
    Intensive Care Med; 2009 Jul; 35(7):1187-95. PubMed ID: 19263034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of pro- and antiapoptotic proteins in circulating CD8+ T cells of patients with squamous cell carcinoma of the head and neck.
    Kim JW; Tsukishiro T; Johnson JT; Whiteside TL
    Clin Cancer Res; 2004 Aug; 10(15):5101-10. PubMed ID: 15297413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transient Bcl-2 gene down-expression in circulating mononuclear cells of severe sepsis patients who died despite appropriate intensive care.
    Bilbault P; Lavaux T; Lahlou A; Uring-Lambert B; Gaub MP; Ratomponirina C; Meyer N; Oudet P; Schneider F
    Intensive Care Med; 2004 Mar; 30(3):408-15. PubMed ID: 14722631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ganoderma spore lipid inhibits N-methyl-N-nitrosourea-induced retinal photoreceptor apoptosis in vivo.
    Gao Y; Deng XG; Sun QN; Zhong ZQ
    Exp Eye Res; 2010 Mar; 90(3):397-404. PubMed ID: 20003911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of antiviral therapy on the immunohistochemical expression of bcl-xL and bax protein in patients with HBeAg-negative chronic hepatitis B.
    Cholongitas E; Papatheodoridis GV; Manesis EK; Petraki K; Tiniakos D; Hadziyannis SJ
    J Med Virol; 2011 Jul; 83(7):1165-71. PubMed ID: 21567420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of Bim and Bid gene expression during accelerated apoptosis in severe sepsis.
    Weber SU; Schewe JC; Lehmann LE; Müller S; Book M; Klaschik S; Hoeft A; Stüber F
    Crit Care; 2008; 12(5):R128. PubMed ID: 18925930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BAX/BCL-XL gene expression ratio inversely correlates with disease progression in chronic myeloid leukemia.
    Gonzalez MS; De Brasi CD; Bianchini M; Gargallo P; Moiraghi B; Bengió R; Larripa IB
    Blood Cells Mol Dis; 2010 Oct; 45(3):192-6. PubMed ID: 20728382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alterations of adiponectin in the course of inflammation and severe sepsis.
    Behnes M; Brueckmann M; Lang S; Putensen C; Saur J; Borggrefe M; Hoffmann U
    Shock; 2012 Aug; 38(3):243-8. PubMed ID: 22744305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. c-Myc overexpression sensitizes Bim-mediated Bax activation for apoptosis induced by histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) through regulating Bcl-2/Bcl-xL expression.
    Jiang X; Tsang YH; Yu Q
    Int J Biochem Cell Biol; 2007; 39(5):1016-25. PubMed ID: 17331788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversal of refractory septic shock with drotrecogin alpha (activated).
    Vieillard-Baron A; Caille V; Charron C; Belliard G; Aegerter P; Page B; Jardin F
    Intensive Care Med; 2009 Jul; 35(7):1204-9. PubMed ID: 19529911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drotrecogin alfa (activated) inhibits NF-kappa B activation and MIP-1-alpha release from isolated mononuclear cells of patients with severe sepsis.
    Brueckmann M; Hoffmann U; Dvortsak E; Lang S; Kaden JJ; Borggrefe M; Haase KK
    Inflamm Res; 2004 Oct; 53(10):528-33. PubMed ID: 15597147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bcl-XL protein levels determine apoptotic index in pancreatic carcinoma.
    Sharma J; Srinivasan R; Majumdar S; Mir S; Radotra BD; Wig JD
    Pancreas; 2005 May; 30(4):337-42. PubMed ID: 15841044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of drotrecogin alfa (activated) on organ dysfunction in the PROWESS trial.
    Vincent JL; Angus DC; Artigas A; Kalil A; Basson BR; Jamal HH; Johnson G; Bernard GR;
    Crit Care Med; 2003 Mar; 31(3):834-40. PubMed ID: 12626993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drotrecogin alfa (activated) may attenuate severe sepsis-associated encephalopathy in clinical septic shock.
    Spapen H; Nguyen DN; Troubleyn J; Huyghens L; Schiettecatte J
    Crit Care; 2010; 14(2):R54. PubMed ID: 20374626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioenergetic failure of human peripheral blood monocytes in patients with septic shock is mediated by reduced F1Fo adenosine-5'-triphosphate synthase activity.
    Japiassú AM; Santiago AP; d'Avila JC; Garcia-Souza LF; Galina A; Castro Faria-Neto HC; Bozza FA; Oliveira MF
    Crit Care Med; 2011 May; 39(5):1056-63. PubMed ID: 21336129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.